Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v5-FR
Language English French
Date Updated 2022-05-05 2022-05-04
Drug Identification Number 02248812 02248812
Brand name ADDERALL XR ADDERALL XR
Common or Proper name Mixed salts amphetamine Mixed salts amphetamine
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients MIXED SALTS AMPHETAMINE MIXED SALTS AMPHETAMINE
Strength(s) 25MG 25MG
Dosage form(s) CAPSULE (EXTENDED RELEASE) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size Bottles of 100's Bottles of 100's
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-04-21 2022-04-21
Actual start date
Estimated end date 2022-06-24 2022-06-24
Actual end date 2022-05-04 2022-05-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments